CURIS, INC. Preferred Stock, Shares Issued
CURIS, INC. (CRIS) had Preferred Stock, Shares Issued of 0 shares as of 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Balance Sheet › Equity › Stockholders' Equity, Number of Shares, Par Value and Other Disclosure › Preferred Stock, Number of Shares, Par Value and Other Disclosure
us-gaap:PreferredStockSharesIssued · last filed 2026-08-14
- 2026-06-30: Preferred Stock, Shares Issued 0.00 shares.
- 2026-03-31: Preferred Stock, Shares Issued 0.00 shares.
- 2025-12-31: Preferred Stock, Shares Issued 0.00 shares.
- 2025-09-30: Preferred Stock, Shares Issued 0.00 shares.
| Period end | Preferred Stock, Shares Issued |
|---|---|
| 2026-06-30 | 0.00 shares 10-Q · filed 2026-08-14 |
| 2026-03-31 | 0.00 shares 10-Q · filed 2026-05-13 |
| 2025-12-31 | 0.00 shares 10-Q · filed 2026-08-14 |
| 2025-09-30 | 0.00 shares 10-Q · filed 2025-11-06 |
| 2025-06-30 | 0.00 shares 10-Q · filed 2025-08-05 |
| 2025-03-31 | 0.00 shares 10-Q · filed 2025-05-06 |
| 2024-12-31 | 0.00 shares 10-K · filed 2026-03-24 |
| 2024-09-30 | 0.00 shares 10-Q · filed 2024-11-14 |
| 2024-06-30 | 0.00 shares 10-Q · filed 2024-08-01 |
| 2024-03-31 | 0.00 shares 10-Q · filed 2024-05-07 |
| 2023-12-31 | 0.00 shares 10-K · filed 2025-03-31 |
| 2023-09-30 | 0.00 shares 10-Q · filed 2023-11-02 |
| 2023-06-30 | 0.00 shares 10-Q · filed 2023-08-03 |
| 2022-12-31 | 0.00 shares 10-K · filed 2024-02-08 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Silexion Therapeutics Corp (SLXN) | $0.001B | ||
| Calidi Biotherapeutics, Inc. (CLDI) | United States | $0.003B | |
| VivoSim Labs, INC. (VIVS) | United States | $0.003B | |
| WINDTREE THERAPEUTICS INC /DE/ (WINT) | United States | $0.003B | -0.32 |
| PharmaCyte Biotech, Inc. (PMCB) | United States | $0.005B | |
| AIM ImmunoTech Inc. (AIM) | United States | $0.006B | |
| CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. (CELZ) | United States | $0.006B | |
| CERO THERAPEUTICS HOLDINGS, INC. (CERO) | United States | $0.007B | |
| TScan Therapeutics, Inc. (TCRX) | United States | $0.008B | -1.23 |
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |